of 16
7/25/2019 A Clinical Study of Otomycosis-jourding
1/16
JOURNAL READING
A CLINICAL STUDYOF OTOMYCOSIS
Present:
Jose Timothy 112012 262
Paskalina 11 2013
248
Conselours :
Dr. Tris Suyartono! S".T#T$%&
Dr. '(us Suar)i! S".T#T$%&
Dr. Santo Prano)o! S".T#T$%&
7/25/2019 A Clinical Study of Otomycosis-jourding
2/16
INTRODUCTION Otomycosisfungal
infction of t! EAC " mi##la$%
Fungi&'( of OE "o))o$tunistic infctions* ++ immunocom)$omis#in#i,i#uals
-$,alnc
!ot !umi# an##usty a$as of t$o)ic an#su.t$o)ics /as fungi a$a.un#ant in soil o$ san# t!atcontains #com)osing,gta.l matt$ai$.o$n0
7/25/2019 A Clinical Study of Otomycosis-jourding
3/16
'nrall an *a+erett t! &stto #sc$i. fungalinfction on t! a$ /As)$gillus an# Can#i#a a$ t!most common s)cis ncount$#0
In EAC* fungal mass #osn1t not )$ot$u#* ,n int! most c!$onic cass% It usually g$o2ing in t!inn$ on3t!i$# of t! EAC%
Otomycosis )$snts 2it! nons)ci4c sym)toms
)$u$itus* #iscomfo$t an# )ain in t! a$* au$alfullnss* tinnitus* !a$ing im)ai$mnt* somtims#isc!a$gs* an# $cu$$nc is common%
7/25/2019 A Clinical Study of Otomycosis-jourding
4/16
-$si#is)osing facto$s fo$otomycosis 5
6a.itual inst$umntation
Un!yginic !a.its
Immunocom)$omis# in#i,i#uals
-$ 7isting a$ #isas
E7tnsi, us of anti.ioticsa$#$o)s* an# c!mot!$a)uticagnts
7/25/2019 A Clinical Study of Otomycosis-jourding
5/16
Otomycosis $cu$$nc to t! t$atmnt #t$min 2!t!$ it1s an isolat# ntityo$ $lat# to any systmic #iso$#$ o$ t!$sult of an u#$lying immuno#4cincy#iso$#$
Diganosis 5 clinical manifstation an#mic$o.iological con4$mation /mic$osco)yan# cultu$0
Main t$atmnt in,ol,s $mo,al of #.$is/toilting of t! 7t$nal a$s0 an# t! usof antimycotic agnts suc! asclot$ima8ol% Also 9)ing t! a$ #$y
7/25/2019 A Clinical Study of Otomycosis-jourding
6/16
Mat$ial an# Mt!o#s
A )$os)cti, stu#y 2as con#uct# on :'' )atints clinically #iagnos# 2it! otomycosis at Out)atint Clinicat S$i ;n9ats2a$a ENT institut* ;icot$ia 6os)ital an#
7/25/2019 A Clinical Study of Otomycosis-jourding
7/16
:'' cass 2$ su.=ct# to acom)$!nsi, !isto$y an#clinical an# la.o$ato$yin,stigation
T! out$ )a$t of )atints1 EAC2as clan# using st$il s2a.san# t! mat$ial f$om t!#)$ )o$tion of t! EAC 2asta9n using st$il au$al s2a.ssnt to mic$o.iology)$ocssing /mic$osco)ic7amination 2it! >O6&'( an#inoculat# o,$ Sa.o$au#1s#7t$os aga$ m#ia fo$ cultu$0
7/25/2019 A Clinical Study of Otomycosis-jourding
8/16
GRA-6 & 5 AGE3?ISEDISTRI
7/25/2019 A Clinical Study of Otomycosis-jourding
9/16
GRA-63: 5 SE@3?ISE DISTRI
7/25/2019 A Clinical Study of Otomycosis-jourding
10/16
GRA-63 5 SYM-TOMS AMONGSTUDY -O-ULATION
:'( )atints !a# all t!sym)toms%
Clinical 7amination canal s9in $yt!ma an#fungus #.$is in all cass%Si7 of t!immunocom)$omis#)atints !a# a small
cnt$al )$fo$ation of t!tym)anic mm.$an.!in# t! !an#l ofmallus% T!y !a# not)$,iously 7)$inc#a$ )ain o$ otitis m#ia%
7/25/2019 A Clinical Study of Otomycosis-jourding
11/16
GRA-63B 5 -REDIS-OSING FACTORS FOR
OTOMYCOSIS IN STUDY -O-ULATION
7/25/2019 A Clinical Study of Otomycosis-jourding
12/16
GRA-63 5 ASSOCIATED MEDICAL6ISTORY IN STUDY -O-ULATION
7/25/2019 A Clinical Study of Otomycosis-jourding
13/16
GRA-63 5 LATERALITYDISTRI
7/25/2019 A Clinical Study of Otomycosis-jourding
14/16
GRA-635 ;ARIOUS FUNGAL ISOLATES IN T6EIMMUNOCOM-ETENT GROU- ANDIMMUNOCOM-ROMISED GROU- IN STUDY
-O-ULATION
7/25/2019 A Clinical Study of Otomycosis-jourding
15/16
,CP,SD *P ,CPTT *P
7/25/2019 A Clinical Study of Otomycosis-jourding
16/16
GRA-63 5 TREATMENT OUTCOME
To)ical
Antifungal
No%
of
cass
&st follo2
u)
:n# follo2
u)
$# follo2
u)
Bt! follo2
u)
Clotrimazole &' Goo#
$s)ons
Goo#
$s)ons
Goo#
$s)ons
NAD
Flucona8ol
:' No
response
Goo#
$s)ons
Goo#
$s)ons
NAD
